Most recently, Pheast Therapeutics raised $24.6M in its Early Stage VC (Oct 2025).
- ·Watch Pheast Therapeutics: the Monday email on marks, rounds and moves
Pheast Therapeutics round by round
2 roundsHow much has Pheast Therapeutics raised?
Pheast Therapeutics has raised $101 million across 2 recorded rounds since 2022. The largest was a $75.3 million later-stage round in Jan 2022; the most recent was a $24.6 million early-stage round in Oct 2025.
Pheast Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently in Apr 2025 ($75.3 million sold to 7 investors).
Pheast Therapeutics investors
4 investors are on record for Pheast Therapeutics, including Alexandria Venture Investments, ARCH Venture Partners, Catalio Capital Management and Rsquared. The early-stage round in Oct 2025 drew 7 investors.
4 investors have backed Pheast Therapeutics.
Frequently asked about Pheast Therapeutics
- How much has Pheast Therapeutics raised?
- Pheast Therapeutics has raised $100.6M in total across 2 recorded funding rounds.
- When was Pheast Therapeutics's last funding round?
- Pheast Therapeutics's most recent recorded round was Early Stage VC in Oct 2025, raising $24.6M.